Stem cells from bone marrow do well in Mayo heart failure trial

04/17/2013 | Daily Express (London)

Heart function improved for all patients who received autologous, bone marrow-derived stem cells in a trial conducted by the Mayo Clinic's Center for Regenerative Medicine in Minnesota, according to a study in the Journal of the American College of Cardiology. The stem cells were modified to act as cardiac cells before being injected into the patients, who were being treated for heart failure.

View Full Article in:

Daily Express (London)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY